Stocks · News reference
Ardent Health shares are trading higher after the company reported better-than-expected Q2 sales results and affirmed its FY26 sales guidance with its midpoint above estimates.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BMO Capital Initiates Coverage On Ardent Health with Market Perform Rating, Announces Price Target of $11
BMO Capital analyst Sean Dodge initiates coverage on Ardent Health (NYSE:ARDT) with a Market Perform rating and announces Price Target of $11.
8-K filing — Ardent Health, Inc. (ARDT)
Filed: 2026-09-04 AccNo: 0001628280-26-060735 Size: 394 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
RBC Capital Maintains Outperform on Ardent Health, Raises Price Target to $13
RBC Capital analyst Ben Hendrix maintains Ardent Health (NYSE:ARDT) with a Outperform and raises the price target from $12 to $13.